SYNAGEVA BIOPHARMA CORP's ticker is and the CUSIP is 87159A953. A total of 1 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,526,000 | +568.3% | 25,900 | +370.9% | 0.04% | +566.7% |
| Q3 2014 | $378,000 | -65.6% | 5,500 | -47.6% | 0.01% | -64.7% |
| Q2 2014 | $1,100,000 | -6.6% | 10,500 | -26.1% | 0.02% | -15.0% |
| Q1 2014 | $1,178,000 | +906.8% | 14,200 | +688.9% | 0.02% | +900.0% |
| Q4 2013 | $117,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 3,400 | $315,000 | 0.00% |